Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen Gurevitz

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Coronary Artery Disease|January 20, 2021
Hospital admissions for acute coronary syndrome during the first wave of COVID-19 pandemic in Israel: a single tertiary center experienceMaya Wiessman, Merry Abitbol, Leor Perl, et al.
Clinical Pharmacology and Therapeutics|February 10, 2026
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity-Matched Cohort StudyInbar Nardi Agmon, Chen Gurevitz, Tzippy Shochat, et al.
Cardiovascular Drugs and Therapy|March 3, 2026
Lipoprotein (a) and Coronary Atherosclerosis in Intracoronary Imaging - YELLOW II - Lp(a) StudyChen Gurevitz, Yuliya Vengrenyuk, Shingo Minatoguchi, et al.
Cardiology|January 24, 2021
Thrombin Generation in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionChen Gurevitz, Alon Eisen, Eli Lev, et al.
European Journal of Preventive Cardiology|September 22, 2025
Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-ITChen Gurevitz, Deepak L Bhatt, Robert P Giugliano, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Coronary Artery Disease|January 20, 2021
Hospital admissions for acute coronary syndrome during the first wave of COVID-19 pandemic in Israel: a single tertiary center experienceMaya Wiessman, Merry Abitbol, Leor Perl, et al.
Clinical Pharmacology and Therapeutics|February 10, 2026
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity-Matched Cohort StudyInbar Nardi Agmon, Chen Gurevitz, Tzippy Shochat, et al.
Cardiovascular Drugs and Therapy|March 3, 2026
Lipoprotein (a) and Coronary Atherosclerosis in Intracoronary Imaging - YELLOW II - Lp(a) StudyChen Gurevitz, Yuliya Vengrenyuk, Shingo Minatoguchi, et al.
Cardiology|January 24, 2021
Thrombin Generation in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionChen Gurevitz, Alon Eisen, Eli Lev, et al.
European Journal of Preventive Cardiology|September 22, 2025
Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-ITChen Gurevitz, Deepak L Bhatt, Robert P Giugliano, et al.
Pageof 3